These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19619989

  • 1. Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).
    Mathai D, Biedenbach DJ, Jones RN, Bell JM, Turnidge J, Sader HS, India Daptomycin Study Group.
    Int J Antimicrob Agents; 2009 Nov; 34(5):497-9. PubMed ID: 19619989
    [No Abstract] [Full Text] [Related]

  • 2. In vitro study to evaluate the sensitivity to daptomycin among gram positive clinical isolates.
    Padmaja K, Umabala P, Prasad KS, Lakshmi V.
    Indian J Med Microbiol; 2012 Nov; 30(1):114-5. PubMed ID: 22361779
    [No Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activities of daptomycin, vancomycin, teicoplanin and linezolid against resistant Gram-positive bacterial isolates from two large centres in western India.
    Biswas S, Watwani J, Vadwai V, Shetty A, Kelkar R, Rodrigues C.
    Int J Antimicrob Agents; 2012 Dec; 40(6):567-9. PubMed ID: 22947124
    [No Abstract] [Full Text] [Related]

  • 4. Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1570-2. PubMed ID: 17220420
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [Abstract] [Full Text] [Related]

  • 6. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
    Sotto A, Laouini D, Bouziges N, Jourdan N, Richard JL, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
    [Abstract] [Full Text] [Related]

  • 7. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
    Castanheira M, Jones RN, Sader HS.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):235-9. PubMed ID: 18314293
    [Abstract] [Full Text] [Related]

  • 8. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
    Steenbergen JN, Mohr JF, Thorne GM.
    J Antimicrob Chemother; 2009 Dec; 64(6):1130-8. PubMed ID: 19825818
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
    Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez HT.
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of in vitro activity of teicoplanin against gram-positive anaerobic bacteria.
    Anzivino D, Nani E, Gulletta E, Lembo M, Covelli B.
    J Chemother; 1989 Jul; 1(4 Suppl):201-2. PubMed ID: 16312368
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [Abstract] [Full Text] [Related]

  • 14. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS, Owens A, Cadena J, Sabol K, Patterson JE, Jorgensen JH.
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract] [Full Text] [Related]

  • 15. Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
    Pfaller MA, Mendes RE, Sader HS, Jones RN.
    J Antimicrob Chemother; 2010 Nov; 65(11):2396-404. PubMed ID: 20846936
    [Abstract] [Full Text] [Related]

  • 16. Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms.
    Tarai B, Das P, Kumar D.
    Indian J Med Microbiol; 2014 Nov; 32(3):353-4. PubMed ID: 25008844
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients.
    Sader HS, Fritsche TR, Jones RN.
    J Chemother; 2008 Oct; 20(5):570-6. PubMed ID: 19028618
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR, Jacobus NV, McDermott LA.
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [Abstract] [Full Text] [Related]

  • 19. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A, Benca G, Duong LS, Augustin A, Havlik S, Liska A, Kalavsky E, Beno P, Krcmery V.
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract] [Full Text] [Related]

  • 20. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
    Hernández Martí V, Romá Sánchez E, Salavert Lletí M, Bosó Ribelles V, Poveda Andrés JL.
    Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.